Today on THCB Spotlight, Matthew sits down with Wellthy’s CEO Lindsay Jurist-Rosner to talk about the healthcare system’s need to support caregivers. Wellthy works in the caregiving space, and Lindsay tells us about the company’s mission to provide a software and platform experience that offers organization and structure to support those who are caring for a loved one. Lindsay also talks to us about her personal inspiration for starting Wellthy and how their business model operates. Wellthy has raised $50 million in total and has closed up $35 million this summer.
THCB Spotlights: Chris Gervais, CTO of Kyruus
Today on THCB Spotlight, Matthew talks with Chris Gervais, the CTO of Kyruus, which began in the world of fixing scheduling for hospital systems. Chris talks more about their recent acquisition of HealthSparq in the last year and what this acquisition means for the future of Kyruus and the audience it serves. Kyruus’ original concept was having good rich accurate and complete provider data. Ultimately, the aim is to build out a rich provider directory spanning a large number of the US provider population, as well as all these other care options for patients to find, that builds transparency and trust.
THCB Spotlights: Dan Goldsmith and Jennifer Goldsmith, Tendo
Today on THCB Spotlight, Matthew sits down with Tendo’s CEO, Dan Goldsmith, and President, Jennifer Goldsmith. Tendo is in the patient engagement space, and Jennifer tells us about the vision behind the company – to become that trusted connection between patients, clinicians, and caregivers via software that creates a seamless and consumer-driven experience throughout that care journey. They talk to us about the plethora of point solutions for patient engagement, and how the platform approach that Tendo takes is meant to support a patient’s comprehensive needs without placing the full burden on the patients themselves.
THCB Spotlights: Shahram Seyedin-Noor, GP of Civilization Ventures
Today, Matthew is back with another THCB Spotlight, this time with Shahram Seyedin-Noor, GP of Civilization Ventures. In this interview, Shahram tells us about how he got into venture and what he was doing before that, as well as his thinking around the focus of Civilization Ventures in catering to a new type of life science entrepreneur.
THCB Spotlights: Marta Zanchi, Founder & Managing Partner at Nina Capital
Today on THCB Spotlight, Matthew sits down with Marta Zanchi, who is the founder and Managing Partner at Nina Capital. Nina Capital is a micro venture capital firm in Barcelona, and in this interview, Matthew asks Marta about her decision to move from Silicon Valley to Barcelona and start this fund. Marta talks us through some of the investments they’ve made in the past couple of years so tune in to find out more.
THCB Spotlights: CJ Wilson, CEO of MyHealth.US
Today on THCB Spotlights, Matthew Holt interviews CJ Wilson, the CEO of MyHealth.US. MyHealth.US provides wearable QR codes for instant access to emergency health information, as well as a digital platform to track your health data and house medical records. CJ shows us some of their offerings and explains how they’re working with unions and schools in NYC along with the company’s future plans for funding and growth.
THCB Gang Episode 22, 8/20
Episode 22 of “The THCB Gang” was live-streamed on Thursday, August 20th! Watch it below.
Joining Matthew Holt (@boltyboy) today are some of our regulars: writer Kim Bellard (@kimbbellard), patient safety expert Michael Millenson (MLMillenson), MD & hospital system exec Rajesh Aggarwal (@docaggarwal), data privacy expert Deven McGraw (@healthprivacy), and Casey Quinlan (@MightyCasey). The conversation revolved around the responsibilities of the CDC & HHS, why the data hasn’t been shared properly around COVID19 transmission, and why payers & providers are cautiously innovating health care.
If you’d rather listen to the episode, the audio is preserved as a weekly podcast available on our iTunes & Spotify channels — Zoya Khan
THCB Spotlights: Paul Johnson, CEO of Lemonaid
Today on THCB Spotlights, Matthew sits down with Paul Johnson, the CEO of Lemonaid. Lemonaid just closed a $33 million Series B led by Olive Tree Ventures, expanding their direct-to-consumer online services which provide primary care visits as well as pharmacy and medication delivery to your home and launching into more chronic areas of care, such as hypertension, high cholesterol, asthma and type 2 diabetes. Why did they wind up with an Israel-focused lead investor in Olive Tree as a San Francisco-based company? Where is Lemonaid in terms of growth and revenue? And how is Lemonaid differentiating itself against some of the other chronic care management and telehealth companies? Find out how the company aims to provide care for patients holistically and be the first point of contact for patients in seeking healthcare.
THCB Spotlights: Allison Martin, UDoTest and Rahul Dubey, AHIP
This is one of the more unusual videos I’ve done as a THCB Spotlight. I’ve been advising Allison Martin at UDoTest for a while. Meanwhile, I met Rahul Dubey when he was running innovation at AHIP. Then I saw his name all over Twitter and everywhere else because he had let a large number of protesters into his house as the police violently broke up a BLM protest earlier this month. What I didn’t know was how well they knew each other, but I got them together late last week and it made for a fascinating conversation about society, health care, and the future. —Matthew Holt
THCB Spotlights: Stacie Ruth, CEO and Nirinjan Yee, Head of Innovation at AireHealth
Stacie Ruth left mega conglomerate Philips when she ran into the chance to revolutionize drug delivery via nebulizers, and co-founded AireHealth. Along the way she realized that changing care for patients with respiratory conditions was actually a bigger problem and opportunity. In April she met Nirinjan Yee from Breath Research who had built an AI system that took lung sounds to predict exacerbations. Last week they merged their companies, and I spoke to them about what the new AireHealth will be doing. —Matthew Holt
